Pelthos Therapeutics Stock Net Income
| PTHS Stock | 26.50 0.48 1.78% |
Fundamental analysis of Pelthos Therapeutics allows traders to better anticipate movements in Pelthos Therapeutics' stock price by examining its financial health and performance throughout various phases of its business cycle.
| Last Reported | Projected for Next Year | ||
| Net Loss | -8 M | -7.6 M | |
| Net Loss | -8 M | -7.6 M | |
| Net Loss | (13.54) | (14.22) |
Pelthos | Net Income | Build AI portfolio with Pelthos Stock |
Pelthos Therapeutics Company Net Income Analysis
Pelthos Therapeutics' Net income is the profit of a company for the reporting period, which is derived after taking revenues and gains and subtracting all expenses and losses. Net income is one of the most-watched numbers by money managers as well as individual investors.
Current Pelthos Therapeutics Net Income | (7.96 M) |
Most of Pelthos Therapeutics' fundamental indicators, such as Net Income, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Pelthos Therapeutics is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Pelthos Net Income Driver Correlations
Understanding the fundamental principles of building solid financial models for Pelthos Therapeutics is extremely important. It helps to project a fair market value of Pelthos Stock properly, considering its historical fundamentals such as Net Income. Since Pelthos Therapeutics' main accounts across its financial reports are all linked and dependent on each other, it is essential to analyze all possible correlations between related accounts. However, instead of reviewing all of Pelthos Therapeutics' historical financial statements, investors can examine the correlated drivers to determine its overall health. This can be effectively done using a conventional correlation matrix of Pelthos Therapeutics' interrelated accounts and indicators.
Click cells to compare fundamentals
Because income is reported on the Income Statement of a company and is measured in dollars some investors prefer to use Profit Margin, which measures income as a percentage of sales.
| Competition |
Pelthos Operating Income
Operating Income |
|
Based on the recorded statements, Pelthos Therapeutics reported net income of (7.96 Million). This is 102.33% lower than that of the Pharmaceuticals sector and 111.36% lower than that of the Health Care industry. The net income for all United States stocks is 101.39% higher than that of the company.
Pelthos Net Income Peer Comparison
Stock peer comparison is one of the most widely used and accepted methods of equity analyses. It analyses Pelthos Therapeutics' direct or indirect competition against its Net Income to detect undervalued stocks with similar characteristics or determine the stocks which would be a good addition to a portfolio. Peer analysis of Pelthos Therapeutics could also be used in its relative valuation, which is a method of valuing Pelthos Therapeutics by comparing valuation metrics of similar companies.Pelthos Therapeutics is currently under evaluation in net income category among its peers.
Pelthos Fundamentals
| EBITDA | (7.17 M) | ||||
| Net Income | (7.96 M) | ||||
| Total Debt | 2.19 M | ||||
| Cash Flow From Operations | (5.79 M) | ||||
| Total Asset | 1.37 M | ||||
| Retained Earnings | (21.47 M) | ||||
| Working Capital | (2.71 M) | ||||
| Net Asset | 1.37 M |
About Pelthos Therapeutics Fundamental Analysis
The Macroaxis Fundamental Analysis modules help investors analyze Pelthos Therapeutics's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of Pelthos Therapeutics using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of Pelthos Therapeutics based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.
Please read more on our fundamental analysis page.
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Pelthos Stock Analysis
When running Pelthos Therapeutics' price analysis, check to measure Pelthos Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Pelthos Therapeutics is operating at the current time. Most of Pelthos Therapeutics' value examination focuses on studying past and present price action to predict the probability of Pelthos Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Pelthos Therapeutics' price. Additionally, you may evaluate how the addition of Pelthos Therapeutics to your portfolios can decrease your overall portfolio volatility.